Compare CELH & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CELH | BIRK |
|---|---|---|
| Founded | 2004 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 6.1B |
| IPO Year | 2008 | 2023 |
| Metric | CELH | BIRK |
|---|---|---|
| Price | $34.38 | $34.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $65.63 | $62.69 |
| AVG Volume (30 Days) | ★ 6.0M | 2.0M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $1,318,014,000.00 | N/A |
| Revenue This Year | $37.60 | $13.76 |
| Revenue Next Year | $10.00 | $14.29 |
| P/E Ratio | $144.22 | ★ $17.48 |
| Revenue Growth | ★ 101.65 | N/A |
| 52 Week Low | $32.36 | $33.06 |
| 52 Week High | $66.74 | $57.39 |
| Indicator | CELH | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 34.30 | 42.33 |
| Support Level | $34.10 | $33.06 |
| Resistance Level | $47.00 | $42.19 |
| Average True Range (ATR) | 1.96 | 1.62 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 12.75 | 38.28 |
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.